Literature DB >> 350780

Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients.

E Murray, S Ruygrok, G W Milton, P Hersey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 350780     DOI： 10.1002/ijc.2910210507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  4 in total

1.  Characterization of an inhibitor of cell division released in tumour cell cultures.

Authors:  J Werkmeister; J Zaunders; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

2.  Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.

Authors:  P Hersey; A Edwards; G D'Alessandro; M MacDonald
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Circulating immune complexes in carcinoma of uterine cervix.

Authors:  P Seth; N Balachandran; A N Malaviya; R Kumar
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

4.  Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays.

Authors:  P Hersey; E Murray; J Werkmeister; W H McCarthy
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.